M86.30

Clinical Causes: The exact cause of chronic multifocal osteomyelitis remains unclear. It may be related to an abnormal immune response that causes inflammation in the bones. Some cases are associated with genetic factors, such as autoinflammatory syndromes. Infections, though less common, can sometimes contribute to bone inflammation. Other potential triggers include minor injuries or preceding infections that lead to persistent inflammation.

Key Symptoms: Persistent bone pain, often localized but can be diffuse. Swelling and tenderness around affected bones. Reduced range of motion in nearby joints, if involved. Fever and malaise in some cases, indicating ongoing inflammation. Fatigue and general feelings of unwellness may be present. Presence of deformities or bone fractures if the condition is long-standing and causes weakening of the bone structure.

Diagnosis Path: Detailed medical history and physical examination to assess symptoms and affected areas. Imaging studies such as X-rays, MRI, or CT scans to visualize bone abnormalities and pinpoint inflamed areas. Laboratory tests including blood work to identify markers of inflammation, such as elevated ESR or CRP levels. Bone biopsy may be conducted to rule out other conditions, including infections or malignancies, and to confirm inflammation. Assessment for associated syndromes or genetic conditions that might contribute to the disease.

Treatment Protocols: Non-steroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. Corticosteroids may be prescribed in more severe cases to suppress immune response. Immunomodulatory therapies, such as biologic agents, especially in cases linked to autoinflammatory syndromes. Physical therapy to maintain joint mobility and muscle strength. Monitoring and managing any bone damage or deformities over time. Surgical intervention, in rare instances, may be necessary to remove necrotic tissue or stabilize fractures. Addressing underlying causes or associated systemic conditions if identified. Long-term follow-up with healthcare providers to monitor disease progression and treatment effectiveness.